Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab
Conditions: Oncology; Biomarker; NSCLC, Stage III; Durvalumab; Chemoradiotherapy Intervention: Other: Non-interventional Sponsors: LMU Klinikum; Department of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich, Munich, Germany; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany; Asklepios Lung Clinic, Munich-Gauting, Germany; Department of Radiology, University Hospital, LMU Munich, Munich, Germany; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; Institute for Medical Information Processing, Biometry and Epi...
Source: ClinicalTrials.gov - August 30, 2021 Category: Research Source Type: clinical trials
The Association Between Catheter-based Absolute Coronary Flow and Resistance and 15O-H2O Positron Emission Tomography Scan Based Absolute Myocardial Blood Flow in the Coronary Artery Territory
Condition: Coronary Artery Disease Interventions: Diagnostic Test: Coronary Physiology; Diagnostic Test: 15O-H2O-PET scan Sponsors: Aarhus University Hospital Skejby; Department of Nuclear Medicine, Aarhus University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials